Prostatic carcinoma in Egypt: epidemiology and etiology
Sherif, M.; Ibrahim, A.S.; El-Aaser, A.A.
Scandinavian Journal of Urology and Nephrology. Supplementum 55: 25-26
1980
ISSN/ISBN: 0300-8886 PMID: 6938031 Document Number: 155054
In Egypt, the relative frequency of prostatic carcinoma is much lower than elsewhere reported. On the other hand, carcinoma of the male breast shows a strikingly higher frequency. These findings could be related to the prevalent bilharzial infestation which impairs the liver detoxication mechanism. As a result there is an increased estrogen and diminished androgen level. These metabolic changes can contribute to the rarity of prostatic cancer and the high frequency of breast cancer in males.
Document emailed within 1 workday
Related Documents
Heras, M.; Sánchez Hernández, R.; Fernández-Reyes, M.J.; Molina, A. 2007: Prostatic carcinoma as acute renal failure of unknown etiology Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(5): 651-652Kaiser, R.; Schulz, K.D. 1983: Current views on the epidemiology and etiology of endometrial carcinoma Der Gynakologe 16(2): 82-86
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Singer, A.; Reid, B.L.; Coppleson, M. 1976: A hypothesis: the role of a high-risk male in the etiology of cervical carcinoma: a correlation of epidemiology and molecular biology American Journal of Obstetrics and Gynecology 126(1): 110-115
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Shimazaki, J.; Fuse, H.; Akimoto, S.; Sumiya, H.; Akakura, K.; Ichikawa, T. 1988: Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 909-916
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Bologna, M.; Festuccia, C.; Vicentini, C.; Muzi, P.; Biordi, L.; De Nicola, G.; Ventura, T. 1991: Establishment and characterization of a human prostatic carcinoma cell strain obtained from exfoliated tumor cells after prostatic massage Tumori 77(1): 70-75
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Shiran, M.S.; Tan, G.C.; Sabariah, A.R.; Rampal, L.; Phang, K.S. 2007: P63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions Medical Journal of Malaysia 62(1): 36-39
Schubert, J.; Gorski, J. 1983: Zum biologischen Verhalten des Prostatakarzinoms. II: Klinisch-operative Studien zur lymphogenen Metastasierung des Prostatakarzinoms - Le comportement biologique du cancer prostatique. II: Etudes clinicochirurgicales sur les métastases lymphogènes du cancer prostatique - Biological behaviour of prostatic carcinoma. II. Clinical operative studies of lymphatic metastasizing of prostatic carcinoma der Urologe. Ausgabe a 22: 356-359
El-Gendy, S.D.; Osman, A.M.; Al-Sherbiny, M.M. 1999: Epidemiology and immunodiagnosis of schistosomiasis haematobium in low endemic area in Egypt Journal of the Egyptian Society of Parasitology 29(1): 229-246
Leńko, J.; Marczyńska, A.; Kulpa, J.; Kwinta, A.; Bugajski, A. 1986: Biochemical control investigations (determinations of prostatic phosphatase--carcinoembryonic antigen alkaline phosphatase) in patients treated for prostatic carcinoma. Preliminary estimation of effectiveness Materia Medica Polona. Polish Journal of Medicine and Pharmacy 18(4): 238-243
Hiraoka, Y.; Sa, I. 2002: Biochemical diagnosis of benign prostatic hyperplasia (including differential diagnosis with prostatic carcinoma) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 342-345
McNeal, J. 1990: Pathology of benign prostatic hyperplasia. Insight into etiology Urologic Clinics of North America 17(3): 477-486
Soulié, M. 2003: Epidemiology of prostatic cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(5 Suppl 2: 1261